Please login to the form below

Not currently logged in
Email:
Password:

Oncodesign

This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.

Sanofi taps Oncodesign for kinase inhibitor platform

Sanofi taps Oncodesign for kinase inhibitor platform

The deal with Sanofi is a major coup for Oncodesign, which to date has signed smaller agreements with partners. ... This new agreement illustrates the leading position of Oncodesign in the kinase inhibitor field," said Oncodesign's chief scientific

Latest news

  • Oncodesign-Ipsen enter Parkinson’s research collaboration

    Oncodesign-Ipsen enter Parkinson’ s research collaboration. French companies to make use of LRRK2 programme to tackle genetic mutations. ... Dr Philippe Genne, CEO of Oncodesign, also described the deal as part of a new direction for his company.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over

  • Pharma deals during September 2012 Pharma deals during September 2012

    Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics